MYCN and neuroblastoma: This interpretation is consistent with the recently published evidence that different pediatric solid cancers relapses share a common generic pattern of clonal expansion and evolution of somatic genomic changes, in which high risk aberrations, such as MYCN amplification in neuroblastoma and TP53 in Wilms tumor lead to complex chromosome changes and anaplastic histological features [48].